Literature DB >> 28082518

Vancomycin-Associated Cast Nephropathy.

Yosu Luque1,2,3, Kevin Louis1, Chantal Jouanneau2, Sandrine Placier2, Emmanuel Esteve2, Dominique Bazin3,4, Eric Rondeau1,2,3, Emmanuel Letavernier2,3,5, Alice Wolfromm6, Clément Gosset7, Anna Boueilh8, Maren Burbach8, Perrine Frère9, Marie-Christine Verpont9, Sophie Vandermeersch2, Dominique Langui10, Michel Daudon2,3,5, Vincent Frochot2,5, Laurent Mesnard11,2,3.   

Abstract

Vancomycin is a widely prescribed antibiotic, but the exact nature of vancomycin-associated nephrotoxicity is unclear, in particular when considering the frequent coadministration of aminoglycosides. We describe here the initial case of a 56-year-old woman with normal renal function developing unexplained ARF without hypovolemia after administration of vancomycin without coadministration of aminoglycosides. Studying the patient's renal biopsy specimen, we ascertained that obstructive tubular casts composed of noncrystal nanospheric vancomycin aggregates entangled with uromodulin explained the vancomycin-associated ARF. We developed in parallel a new immunohistologic staining technique to detect vancomycin in renal tissue and confirmed retrospectively that deleterious vancomycin-associated casts existed in eight additional patients with acute tubular necrosis in the absence of hypovolemia. Concomitant high vancomycin trough plasma levels had been observed in each patient. We also reproduced experimentally the toxic and obstructive nature of vancomycin-associated cast nephropathy in mice, which we detected using different in vivo imaging techniques. In conclusion, the interaction of uromodulin with nanospheric vancomycin aggregates represents a new mode of tubular cast formation, revealing the hitherto unsuspected mechanism of vancomycin-associated renal injury.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  acute renal failure; acute tubular necrosis; tubular cast; tubular epithelium; vancomycin

Mesh:

Substances:

Year:  2017        PMID: 28082518      PMCID: PMC5461798          DOI: 10.1681/ASN.2016080867

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  14 in total

1.  In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.

Authors:  Faruk Oktem; Meltem Koyuncu Arslan; Fehmi Ozguner; Ozden Candir; H Ramazan Yilmaz; Metin Ciris; Efkan Uz
Journal:  Toxicology       Date:  2005-08-19       Impact factor: 4.221

2.  Vancomycin: a history.

Authors:  Donald P Levine
Journal:  Clin Infect Dis       Date:  2006-01-01       Impact factor: 9.079

3.  Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.

Authors:  Lindsey D Burgess; Richard H Drew
Journal:  Pharmacotherapy       Date:  2014-05-22       Impact factor: 4.705

Review 4.  Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.

Authors:  S J van Hal; D L Paterson; T P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2012-11-19       Impact factor: 5.191

5.  Introduction to vancomycin.

Authors:  R S Griffith
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

6.  Nephrotoxicity of vancomycin, alone and with an aminoglycoside.

Authors:  M J Rybak; L M Albrecht; S C Boike; P H Chandrasekar
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

7.  Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.

Authors:  Thomas P Lodise; Ben Lomaestro; Jeffrey Graves; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

8.  Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.

Authors:  B F Farber; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Authors:  Ronald G Hall; Kathleen A Hazlewood; Sara D Brouse; Christopher A Giuliano; Krystal K Haase; Chistopher R Frei; Nicolas A Forcade; Todd Bell; Roger J Bedimo; Carlos A Alvarez
Journal:  BMC Pharmacol Toxicol       Date:  2013-02-13       Impact factor: 2.483

10.  Exposure to Hyperbaric Oxygen Intensified Vancomycin-Induced Nephrotoxicity in Rats.

Authors:  Itay M Sabler; Matitiahu Berkovitch; Judith Sandbank; Eran Kozer; Zahi Dagan; Michael Goldman; Hilla Bahat; Kobi Stav; Amnon Zisman; Baruch Klin; Ibrahim Abu-Kishk
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

View more
  41 in total

Review 1.  Pharmacology behind Common Drug Nephrotoxicities.

Authors:  Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

Review 2.  Mechanisms of antimicrobial-induced nephrotoxicity in children.

Authors:  Kevin J Downes; Molly Hayes; Julie C Fitzgerald; Gwendolyn M Pais; Jiajun Liu; Nicole R Zane; Stuart L Goldstein; Marc H Scheetz; Athena F Zuppa
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

Review 3.  Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways.

Authors:  Allison A Eddy
Journal:  Pediatr Nephrol       Date:  2019-02-28       Impact factor: 3.714

4.  Vancomycin in the Kidney-A Novel Cast Nephropathy.

Authors:  M Barry Stokes
Journal:  J Am Soc Nephrol       Date:  2017-03-07       Impact factor: 10.121

5.  Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial Therapy.

Authors:  Claire Triffault-Fillit; Florent Valour; Ronan Guillo; Michel Tod; Sylvain Goutelle; Sébastien Lustig; Michel-Henry Fessy; Christian Chidiac; Tristan Ferry
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 6.  [Prevention of acute kidney injury in critically ill patients : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  M Joannidis; S J Klein; S John; M Schmitz; D Czock; W Druml; A Jörres; D Kindgen-Milles; J T Kielstein; M Oppert; V Schwenger; C Willam; A Zarbock
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-03-28       Impact factor: 0.840

Review 7.  Expanding the Role for Kidney Biopsies in Acute Kidney Injury.

Authors:  Sushrut S Waikar; Gearoid M McMahon
Journal:  Semin Nephrol       Date:  2018-01       Impact factor: 5.299

8.  Evaluation of the stability of vancomycin solutions at concentrations used in clinical services.

Authors:  Morgane Masse; Stéphanie Genay; Anthony Martin Mena; Natacha Carta; Damien Lannoy; Christine Barthélémy; Bertrand Décaudin; Pascal Odou
Journal:  Eur J Hosp Pharm       Date:  2020-02-05

Review 9.  Drug-Induced Kidney Injury in the Elderly.

Authors:  Sana Khan; Valentina Loi; Mitchell H Rosner
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

10.  Elevated Vancomycin Trough Levels in a Tertiary Health System: Frequency, Risk Factors, and Prognosis.

Authors:  Reza Zonozi; Aozhou Wu; Jung-Im Shin; Alex Secora; Josef Coresh; Lesley A Inker; Alex R Chang; Morgan E Grams
Journal:  Mayo Clin Proc       Date:  2019-01       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.